查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1243290

GMP細胞庫服務的全球市場

GMP Cell Banking Services
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

GMP細胞庫服務的全球市場在2030年前將達到20億美元

在COVID-19後改變的商務環境中，2022年6億3,600萬美元的GMP細胞庫服務的全球市場，在2022年～2030年預計將以年複合成長率 15.1％的速度成長，在2030年前將達到20億美元的規模。本報告所分析之市場區隔之一的哺乳類，年複合成長率將記錄16％，到分析期間結束時將達到13億美元。考慮疫情後的復甦，微生物領域今後8年的年複合成長率將修正為14.1％。

美國市場估算為1億9,250萬美元，中國則以年複合成長率14.3％成長

美國的GMP細胞庫服務市場在2022年估算為1億9,250萬美元。作為世界第2大經濟大國的中國，在2022年～2030年預計將以年複合成長率14.3％，在2030年前將達到3億3,220萬美元的市場規模。其他熱門的地區市場有日本和加拿大，在2022年～2030年預計將各以13.2％和12.8％的速度成長。在歐洲市場中，德國以年複合成長率10.8％成長。

調查對像企業範例

  • Austrianova Singapore Pte Ltd.
  • Charles River Laboratories International, Inc.
  • Eurofins Scientific SE
  • Goodwin Biotechnology, Inc.
  • Lonza Group AG
  • Merck KgaA
  • Paragon Bioservices, Inc.
  • SGS India Pvt. Ltd.
  • ViruSure GmbH
  • WuXi AppTec

目錄

第1章 調查手法

第2章 摘要整理

  • 市場概要
  • 主要企業
  • 市場趨勢與推動因素
  • 全球市場預測

第3章 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲
  • 亞太地區
  • 全球其他地區

第4章 競爭

簡介目錄
Product Code: MCP12206

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global GMP Cell Banking Services Market to Reach $2 Billion by 2030

In the changed post COVID-19 business landscape, the global market for GMP Cell Banking Services estimated at US$636 Million in the year 2022, is projected to reach a revised size of US$2 Billion by 2030, growing at aCAGR of 15.1% over the period 2022-2030. Mammalian, one of the segments analyzed in the report, is projected to record 16% CAGR and reach US$1.3 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Microbial segment is readjusted to a revised 14.1% CAGR for the next 8-year period.

The U.S. Market is Estimated at $192.5 Million, While China is Forecast to Grow at 14.3% CAGR

The GMP Cell Banking Services market in the U.S. is estimated at US$192.5 Million in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$332.2 Million by the year 2030 trailing a CAGR of 14.3% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 13.2% and 12.8% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 10.8% CAGR.

Select Competitors (Total 41 Featured) -

  • Austrianova Singapore Pte Ltd.
  • Charles River Laboratories International, Inc.
  • Eurofins Scientific SE
  • Goodwin Biotechnology, Inc.
  • Lonza Group AG
  • Merck KgaA
  • Paragon Bioservices, Inc.
  • SGS India Pvt. Ltd.
  • ViruSure GmbH
  • WuXi AppTec

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • GMP Cell Banking Services - Global Key Competitors Percentage Market Share in 2020 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2020 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for GMP Cell Banking Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 2: World 8-Year Perspective for GMP Cell Banking Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2023 & 2030
    • TABLE 3: World Recent Past, Current & Future Analysis for Mammalian by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 4: World 8-Year Perspective for Mammalian by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Microbial by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 6: World 8-Year Perspective for Microbial by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Insect by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 8: World 8-Year Perspective for Insect by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 9: World Recent Past, Current & Future Analysis for Yeast by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 10: World 8-Year Perspective for Yeast by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Avian by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 12: World 8-Year Perspective for Avian by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Other Cell Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 14: World 8-Year Perspective for Other Cell Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 15: World Recent Past, Current & Future Analysis for Biopharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 16: World 8-Year Perspective for Biopharmaceutical Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 17: World GMP Cell Banking Services Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Contract Manufacturing Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 19: World 8-Year Perspective for Contract Manufacturing Organizations by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • GMP Cell Banking Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for GMP Cell Banking Services by Cell Type - Mammalian, Microbial, Yeast, Insect, Avian and Other Cell Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 21: USA 8-Year Perspective for GMP Cell Banking Services by Cell Type - Percentage Breakdown of Value Sales for Mammalian, Microbial, Yeast, Insect, Avian and Other Cell Types for the Years 2023 & 2030
    • TABLE 22: USA Recent Past, Current & Future Analysis for GMP Cell Banking Services by End-Use - Biopharmaceutical Companies and Contract Manufacturing Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 23: USA 8-Year Perspective for GMP Cell Banking Services by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies and Contract Manufacturing Organizations for the Years 2023 & 2030
  • CANADA
    • TABLE 24: Canada Recent Past, Current & Future Analysis for GMP Cell Banking Services by Cell Type - Mammalian, Microbial, Yeast, Insect, Avian and Other Cell Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 25: Canada 8-Year Perspective for GMP Cell Banking Services by Cell Type - Percentage Breakdown of Value Sales for Mammalian, Microbial, Yeast, Insect, Avian and Other Cell Types for the Years 2023 & 2030
    • TABLE 26: Canada Recent Past, Current & Future Analysis for GMP Cell Banking Services by End-Use - Biopharmaceutical Companies and Contract Manufacturing Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 27: Canada 8-Year Perspective for GMP Cell Banking Services by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies and Contract Manufacturing Organizations for the Years 2023 & 2030
  • JAPAN
    • GMP Cell Banking Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 28: Japan Recent Past, Current & Future Analysis for GMP Cell Banking Services by Cell Type - Mammalian, Microbial, Yeast, Insect, Avian and Other Cell Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 29: Japan 8-Year Perspective for GMP Cell Banking Services by Cell Type - Percentage Breakdown of Value Sales for Mammalian, Microbial, Yeast, Insect, Avian and Other Cell Types for the Years 2023 & 2030
    • TABLE 30: Japan Recent Past, Current & Future Analysis for GMP Cell Banking Services by End-Use - Biopharmaceutical Companies and Contract Manufacturing Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 31: Japan 8-Year Perspective for GMP Cell Banking Services by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies and Contract Manufacturing Organizations for the Years 2023 & 2030
  • CHINA
    • GMP Cell Banking Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 32: China Recent Past, Current & Future Analysis for GMP Cell Banking Services by Cell Type - Mammalian, Microbial, Yeast, Insect, Avian and Other Cell Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 33: China 8-Year Perspective for GMP Cell Banking Services by Cell Type - Percentage Breakdown of Value Sales for Mammalian, Microbial, Yeast, Insect, Avian and Other Cell Types for the Years 2023 & 2030
    • TABLE 34: China Recent Past, Current & Future Analysis for GMP Cell Banking Services by End-Use - Biopharmaceutical Companies and Contract Manufacturing Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 35: China 8-Year Perspective for GMP Cell Banking Services by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies and Contract Manufacturing Organizations for the Years 2023 & 2030
  • EUROPE
    • GMP Cell Banking Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 36: Europe Recent Past, Current & Future Analysis for GMP Cell Banking Services by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 37: Europe 8-Year Perspective for GMP Cell Banking Services by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2023 & 2030
    • TABLE 38: Europe Recent Past, Current & Future Analysis for GMP Cell Banking Services by Cell Type - Mammalian, Microbial, Yeast, Insect, Avian and Other Cell Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 39: Europe 8-Year Perspective for GMP Cell Banking Services by Cell Type - Percentage Breakdown of Value Sales for Mammalian, Microbial, Yeast, Insect, Avian and Other Cell Types for the Years 2023 & 2030
    • TABLE 40: Europe Recent Past, Current & Future Analysis for GMP Cell Banking Services by End-Use - Biopharmaceutical Companies and Contract Manufacturing Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 41: Europe 8-Year Perspective for GMP Cell Banking Services by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies and Contract Manufacturing Organizations for the Years 2023 & 2030
  • FRANCE
    • GMP Cell Banking Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 42: France Recent Past, Current & Future Analysis for GMP Cell Banking Services by Cell Type - Mammalian, Microbial, Yeast, Insect, Avian and Other Cell Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 43: France 8-Year Perspective for GMP Cell Banking Services by Cell Type - Percentage Breakdown of Value Sales for Mammalian, Microbial, Yeast, Insect, Avian and Other Cell Types for the Years 2023 & 2030
    • TABLE 44: France Recent Past, Current & Future Analysis for GMP Cell Banking Services by End-Use - Biopharmaceutical Companies and Contract Manufacturing Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 45: France 8-Year Perspective for GMP Cell Banking Services by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies and Contract Manufacturing Organizations for the Years 2023 & 2030
  • GERMANY
    • GMP Cell Banking Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 46: Germany Recent Past, Current & Future Analysis for GMP Cell Banking Services by Cell Type - Mammalian, Microbial, Yeast, Insect, Avian and Other Cell Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 47: Germany 8-Year Perspective for GMP Cell Banking Services by Cell Type - Percentage Breakdown of Value Sales for Mammalian, Microbial, Yeast, Insect, Avian and Other Cell Types for the Years 2023 & 2030
    • TABLE 48: Germany Recent Past, Current & Future Analysis for GMP Cell Banking Services by End-Use - Biopharmaceutical Companies and Contract Manufacturing Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 49: Germany 8-Year Perspective for GMP Cell Banking Services by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies and Contract Manufacturing Organizations for the Years 2023 & 2030
  • ITALY
    • TABLE 50: Italy Recent Past, Current & Future Analysis for GMP Cell Banking Services by Cell Type - Mammalian, Microbial, Yeast, Insect, Avian and Other Cell Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 51: Italy 8-Year Perspective for GMP Cell Banking Services by Cell Type - Percentage Breakdown of Value Sales for Mammalian, Microbial, Yeast, Insect, Avian and Other Cell Types for the Years 2023 & 2030
    • TABLE 52: Italy Recent Past, Current & Future Analysis for GMP Cell Banking Services by End-Use - Biopharmaceutical Companies and Contract Manufacturing Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 53: Italy 8-Year Perspective for GMP Cell Banking Services by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies and Contract Manufacturing Organizations for the Years 2023 & 2030
  • UNITED KINGDOM
    • GMP Cell Banking Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 54: UK Recent Past, Current & Future Analysis for GMP Cell Banking Services by Cell Type - Mammalian, Microbial, Yeast, Insect, Avian and Other Cell Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 55: UK 8-Year Perspective for GMP Cell Banking Services by Cell Type - Percentage Breakdown of Value Sales for Mammalian, Microbial, Yeast, Insect, Avian and Other Cell Types for the Years 2023 & 2030
    • TABLE 56: UK Recent Past, Current & Future Analysis for GMP Cell Banking Services by End-Use - Biopharmaceutical Companies and Contract Manufacturing Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 57: UK 8-Year Perspective for GMP Cell Banking Services by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies and Contract Manufacturing Organizations for the Years 2023 & 2030
  • REST OF EUROPE
    • TABLE 58: Rest of Europe Recent Past, Current & Future Analysis for GMP Cell Banking Services by Cell Type - Mammalian, Microbial, Yeast, Insect, Avian and Other Cell Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 59: Rest of Europe 8-Year Perspective for GMP Cell Banking Services by Cell Type - Percentage Breakdown of Value Sales for Mammalian, Microbial, Yeast, Insect, Avian and Other Cell Types for the Years 2023 & 2030
    • TABLE 60: Rest of Europe Recent Past, Current & Future Analysis for GMP Cell Banking Services by End-Use - Biopharmaceutical Companies and Contract Manufacturing Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 61: Rest of Europe 8-Year Perspective for GMP Cell Banking Services by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies and Contract Manufacturing Organizations for the Years 2023 & 2030
  • ASIA-PACIFIC
    • GMP Cell Banking Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 62: Asia-Pacific Recent Past, Current & Future Analysis for GMP Cell Banking Services by Cell Type - Mammalian, Microbial, Yeast, Insect, Avian and Other Cell Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 63: Asia-Pacific 8-Year Perspective for GMP Cell Banking Services by Cell Type - Percentage Breakdown of Value Sales for Mammalian, Microbial, Yeast, Insect, Avian and Other Cell Types for the Years 2023 & 2030
    • TABLE 64: Asia-Pacific Recent Past, Current & Future Analysis for GMP Cell Banking Services by End-Use - Biopharmaceutical Companies and Contract Manufacturing Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 65: Asia-Pacific 8-Year Perspective for GMP Cell Banking Services by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies and Contract Manufacturing Organizations for the Years 2023 & 2030
  • REST OF WORLD
    • TABLE 66: Rest of World Recent Past, Current & Future Analysis for GMP Cell Banking Services by Cell Type - Mammalian, Microbial, Yeast, Insect, Avian and Other Cell Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 67: Rest of World 8-Year Perspective for GMP Cell Banking Services by Cell Type - Percentage Breakdown of Value Sales for Mammalian, Microbial, Yeast, Insect, Avian and Other Cell Types for the Years 2023 & 2030
    • TABLE 68: Rest of World Recent Past, Current & Future Analysis for GMP Cell Banking Services by End-Use - Biopharmaceutical Companies and Contract Manufacturing Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 69: Rest of World 8-Year Perspective for GMP Cell Banking Services by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies and Contract Manufacturing Organizations for the Years 2023 & 2030

IV. COMPETITION